A Message from the President
President and CEO
My name is Hiroshi Nomura, and I have been given the honor of taking office as Representative Director, President and CEO of Sumitomo Dainippon Pharma Co., Ltd.
The single most important responsibility that I have been given is to ensure the sustainable growth of our company into the future. As such, I will make the most efficient use of all resources available to us, unite our individual strengths, and leverage our wealth of experience so that we can successfully take on this challenge. At the same time, I hope to meet the expectations of all stakeholders in our endeavors to attain this overriding goal.
Sumitomo Dainippon Pharma Co., Ltd., operates every day to achieve its corporate mission "to broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide". By pouring all our efforts into the research and development of new drugs, we aim to provide innovative and effective pharmaceutical solutions to people not only in Japan but also around the world in order to realize our corporate mission.
While making renewed efforts to promote innovation, we have taken strategic approaches to our business activities and fortified our business foundations in the relentless pursuit of sustainable growth. Going forward, we will remain committed to research and development by taking every available opportunity to assimilate cutting-edge technologies through combinations of a wide variety of avenues, including in-house research, technology in-licensing, and joint research with biotech companies and academia, with the aim of continually discovering excellent pharmaceutical products in the focus therapeutic areas of Psychiatry & Neurology, Oncology, and Regenerative Medicine and Cell Therapy. Furthermore, we will explore new opportunities in digital healthcare and other new business fields (Frontier areas) going forward.
To implement CSR management, we not only promote our corporate governance system and thoroughly ensure compliance but also fulfill our social responsibility as a corporation through wide-ranging initiatives that include social contribution activities in and outside Japan, promotion of diversification, and active communication with diverse stakeholders.
Always aware of our responsibility to all of our stakeholders, including patients, their families, medical caregivers, our shareholders, employees, and the communities in which we work, we promise to give our most dedicated efforts to earn and maintain your trust in us.
On behalf of all of us at Sumitomo Dainippon Pharma, I would like to sincerely thank you for your continued support and encouragement.